Moncef Slaoui, head of the U.S. government’s efforts to develop a COVID-19 vaccine, expressed hope that the first Americans will be vaccinated by the second week of December.
“Our plan is to ensure that the vaccine can be delivered to the vaccination site within 24 hours of approval, so we expect the first people to be vaccinated on the 2nd day after approval, December 11th or 12th. Slaoui spoke with CNN’s Jake Tapper on Sunday’s “State of the Union” in an interview with CNN’s Jake Tapper across the United States, in every state, and in every region where state health departments will tell us where to deliver the vaccine to us.
Friday (November 20) U.S. pharmaceutical giant Pfizer filed an application for emergency use of a Covid-19 vaccine candidate to the U.S. Food and Drug Administration. We learned that the FDA Vaccine Advisory Committee is scheduled to make a decision in this regard through a December 10 meeting.
Slaoui, with the level of efficacy shown by both the Pfizer vaccine and the modder or vaccine, “will allow about 70% of the immunized population to allow true herd immunity to occur, which will happen somewhere in May. So according to our plan. “
Pfizer reported the vaccine’s 95% efficacy and said urgent use of the vaccine could start the process early.
According to Slaoui, 20 million people across the United States will be vaccinated in December, and about 30 million will be vaccinated a month after that.
Meanwhile, the developers of Sputnik V argued that the price of the Russian coronavirus vaccine Sputnik V would be lower than the vaccine developed by Pfizer and Moderna.
“Pharmaceutical Terminology Translation: Pfizer’s published price is US$19.50 per dose (Rs 1446), Modena price is US$25 to US$37 per dose (Rs 1854.07-2744.02) and actually costs $39 (2892.34) Dollars) and 50 to 74 dollars. (Rs 3708.13-5488.04) per person. Pfizer, Sputnik V and Modena vaccines require 2 doses per person. The price of Sputnik V will be much lower. “